Akèy › Kansè Poumon ki pa ti selil › Missouri › Springfield
Etid klinik pou Kansè Poumon ki pa ti selil nan Springfield, MO
10 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Springfield (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Ap rekriteFaz 2
- Oncology Hematology Associates, Springfield
Pan-tumor MRD Study
Ap rekriteEtid obsèvasyon
- Cox Health, Springfield
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Ap rekriteFaz 2
- Mercy Hospital Springfield, Springfield
- CoxHealth South Hospital, Springfield
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Ap rekriteFaz 3
- Hulston Cancer Center /ID# 232226, Springfield
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Ap rekriteFaz 3
- Cox Medical Center North ( Site 0133), Springfield
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Ap rekriteFaz 3
- Oncology Hematology Associates, Springfield
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Ap rekriteFaz 3
- Mercy Hospital Springfield, Springfield
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Ap rekriteEtid obsèvasyon
- Mercy Hospital - SPG, Springfield
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Ap rekriteEtid obsèvasyon
- Mercy Hospital Springfield, Springfield
- Cox Health South Hospital, Springfield
GEMINI-NSCLC: NSCLC Biomarker Study
Ap rekriteEtid obsèvasyon
- Mercy Clinic Cancer and Hematology - Chub O'Reilly Cancer Center, Springfield
- Oncology Hematology Associates, Springfield
Etid Kansè Poumon ki pa ti selil nan lòt vil
- Houston, TX145 etid
- New York City, NY120 etid
- Arlington, VA104 etid
- Nashville, TN97 etid
- Boston, MA90 etid
- Los Angeles, CA87 etid
- St. Louis, MO73 etid
- Chicago, IL61 etid
- Baltimore, MD60 etid
- San Antonio, TX59 etid
- Columbus, OH56 etid
- Washington, DC55 etid
Lòt etid nan Springfield
- Kansè kolorektal11 etid
- Kansè (tout kalite)10 etid
- Kansè nan tete10 etid
- Sipwa7 etid
- Obèsite7 etid
- Kansè Metastatik6 etid
- Melanom6 etid
- Kansè poumon6 etid
- Kansè ovè5 etid
- Kansè kolon5 etid
- Kansè pwostat4 etid
- Kansè vejik4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.